首頁 › 大腸直腸癌 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 大腸直腸癌 臨床試驗
8 項針對 大腸直腸癌 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
PRE-ISPY Phase I/II Oncology Platform Program
招募中1/2 期
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's Hospital of Alabama, Birmingham
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of Alabama at Birmingham, Birmingham
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
招募中1 期
- Uni of Alabama at Birmingham, Birmingham
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
招募中歡迎健康志工
- UAB, Birmingham
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
招募中4 期
- Central Alabama Research, Birmingham
- University of Alabama at Birmingham, Birmingham
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
招募中
- The University of Alabama at Birmingham, Birmingham
其他城市的 大腸直腸癌 試驗
- Houston, TX102 項研究
- New York City, NY78 項研究
- Nashville, TN69 項研究
- Boston, MA63 項研究
- Los Angeles, CA59 項研究
- Arlington, VA52 項研究
- St. Louis, MO50 項研究
- San Antonio, TX46 項研究
- Philadelphia, PA44 項研究
- Grand Rapids, MI40 項研究
- Baldwin Park, CA37 項研究
- Chicago, IL34 項研究
Birmingham 的其他研究
- 癌症（所有類型）31 項研究
- 乳癌24 項研究
- 卵巢癌23 項研究
- 肥胖症23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 第二型糖尿病16 項研究
- 子宮內膜癌16 項研究
- 過重16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。